Skip to main content
Print Save

ZA-37 150 mg (Venlafaxine Hydrochloride Extended Release 150 mg)

Pill with imprint ZA-37 150 mg is Orange & White, Capsule-shape and has been identified as Venlafaxine Hydrochloride Extended Release 150 mg. It is supplied by Zydus Pharmaceuticals USA Inc.

Venlafaxine is used in the treatment of autism; anxiety; generalized anxiety disorder; depression; major depressive disorder and belongs to the drug class serotonin-norepinephrine reuptake inhibitors. Risk cannot be ruled out during pregnancy. Venlafaxine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for ZA-37 150 mg

Venlafaxine hydrochloride extended release 150 mg ZA-37 150 mg
Venlafaxine hydrochloride extended release 150 mg ZA-37 150 mg
Venlafaxine hydrochloride extended release 150 mg ZA-37 150 mg

Venlafaxine Hydrochloride Extended Release

Imprint
ZA-37 150 mg
Strength
150 mg
Color
Orange & White
Size
21.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Serotonin-norepinephrine reuptake inhibitors
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Zydus Pharmaceuticals USA Inc.
Inactive Ingredients
silicon dioxide, cetostearyl alcohol, gelatin, hypromelloses, microcrystalline cellulose, sodium lauryl sulfate, magnesium silicate, titanium dioxide, ferric oxide red, ferrosoferric oxide

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
68382-0036 Zydus Pharmaceuticals (USA) Inc.
60429-0123 (Discontinued) Golden State Medical Supply (repackager)
Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer